Colesevelam and Colestipol
Authors:
- Michael A. ArnoldMAMichael A. Arnold
- Benjamin J. SwansonBSBenjamin J. Swanson
- Clinton D. CrowderCCClinton D. Crowder
- Wendy L. FrankelWFWendy L. Frankel
- Dora Lam-HimlinDLDora Lam-Himlin
- Aatur D. SinghiASAatur D. Singhi
- Peter P. StanichPSPeter P. Stanich
- Christina A. ArnoldCAChristina A. Arnold
- 1 November 2014
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 38 (11) , 1530-1537
Abstract
We report the morphologic description of the bile acid sequestrants (BAS) colesevelam and colestipol, as well as the largest series of cholestyramine. Histologically similar medication resins from 4 institutions were prospectively collected over 1 year (26 specimens, 15 patients). Comorbidities included hyperlipidemia (4/15), hypertension (4/15), inflammatory bowel disease (4/15), coronary artery disease (3/15), diarrhea (7/15), hypothyroidism (2/15), and ischemic bowel (1/15). Sites of involvement included the esophagus (1/26), stomach (1/26), small intestine (1/26), ileocecal valve (1/26), and colorectum (22/26). Associated histologic diagnoses included normal (8/26), chronic mucosal injury (11/26), acute inflammation (9/26), erosion/ulceration (6/26), and cytomegalovirus (2/26). The BAS resins were histologically indistinguishable from each other; they were all eosinophilic on hematoxylin and eosin (H&E) and lacked internal "fish-scales." To validate these observations, respective medications were submitted for histologic processing; the processed medications were identical to those in the patient specimens. Rare, irregular "fracture" lines presented diagnostic pitfalls by mimicking the true "fish-scales" of Kayexalate and sevelamer. Clues to the correct identification of BAS include recognition that the "fracture" lines were subtle, irregular, and restricted to large fragments or thick sections, likely representing a processing artifact. Moreover, Kayexalate is violet on H&E and black on acid fast bacillus, and sevelamer characteristically displays a 2-tone color on H&E and is magenta on acid fast bacillus. An association with inflammatory injury was seen (15/26). We believe that the BAS are innocent bystanders in complicated patients, although we cannot exclude their ability to cause mucosal injury in specific settings.Keywords
This publication has 20 references indexed in Scilit:
- Sevelamer Crystals in the Gastrointestinal Tract (GIT)American Journal of Surgical Pathology, 2013
- 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive SummaryCirculation, 2012
- The Potent Bile Acid Sequestrant Colesevelam Is Not Effective in Cholestatic Pruritus: Results of a Double-Blind, Randomized, Placebo-Controlled TrialHepatology, 2010
- Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea‐predominant irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 2009
- Colesevelam hydrochlorideAmerican Journal of Health-System Pharmacy, 2002
- Effectiveness of Colesevelam Hydrochloride in Decreasing LDL Cholesterol in Patients With Primary Hypercholesterolemia: A 24-Week Randomized Controlled TrialMayo Clinic Proceedings, 2001
- Colesevelam Hydrochloride: A Novel Bile Acid-Binding ResinAnnals of Pharmacotherapy, 2001
- Upper Gastrointestinal Tract Injury in Patients Receiving Kayexalate (Sodium Polystyrene Sulfonate) in SorbitolAmerican Journal of Surgical Pathology, 2001
- Necrosis of the Gastrointestinal Tract in Uremic Patients as a Result of Sodium Polystyrene Sulfonate (Kayexalate) in SorbitolAmerican Journal of Surgical Pathology, 1997
- Colonic necrosis following sodium polystyrene sulfonate (Kayexalate®)-sorbitol enema in a renal transplant patientDiseases of the Colon & Rectum, 1993